As an insurance-friendly provider, the final price depends on your insurance
A JP Morgan healthcare sector report published in August, Sick As A Dog by Michael Cembalest, reported Merck to have an estimated $80 Billion of acquisition capacity making Viking well within an affordable bracket if Viking were to demand a premium price tag above the $10 Billion Metsera price tag
Factors such as Medicaid coverage, income levels, age, and healthcare infrastructure play a crucial role in determining who can currently benefit from these medications, and addressing these disparities will be key to maximizing access to GLP-1 therapies in the years ahead
As a family business with global reach, we pride ourselves on being dependable, consistent, and collaborative
There is no FDA-approved pharmacological treatment for sleep apnea
Nicole, Kristina and Erica are the absolute BEST